MedTrace Logo

Device Based Therapy in Hypertension Trial

NCT00710190 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2016-10-21

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the safety and efficacy of the Rheos Baroreflex Hypertension Therapy System in patients with refractory hypertension.

Conditions

Interventions

DEVICE

Rheos Baroreflex Hypertension Therapy System

This therapy uses implantable device-based electrical activation of the carotid sinus baroreflex to control blood pressure.

Sponsors & Collaborators

  • CVRx, Inc.

    lead INDUSTRY

Principal Investigators

  • Thomas Baal, PhD · CVRx, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Czechia
  • Germany
  • Latvia
  • Netherlands
  • Poland
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00710190 on ClinicalTrials.gov